ONO 1301

Drug Profile

ONO 1301

Alternative Names: AP 50002; ONO 1301 - slow-release; ONO AP 50002; ONO-1301MS; SR-ONO

Latest Information Update: 15 Oct 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Class Acetic acids; Anti-inflammatories; Antiplatelets; Pyridines; Small molecules
  • Mechanism of Action Epoprostenol agonists; Thromboxane synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Myocardial ischaemia; Pulmonary fibrosis
  • Discontinued Thrombosis

Most Recent Events

  • 15 Oct 2010 Preclinical development is ongoing in Japan
  • 22 Sep 2010 Pharmacodynamics data from a preclinical trial in Pulmonary fibrosis presented at the 20th Annual Congress of the European Respiratory Society (ERS-2010)
  • 22 Dec 2005 Preclinical trials in Myocardial ischaemia in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top